Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;58(6):357-366.
doi: 10.5114/reum.2020.102000. Epub 2020 Dec 23.

The complement system in primary Sjögren's syndrome: the expression of certain cascade and regulatory proteins in labial salivary glands - observational study

Affiliations

The complement system in primary Sjögren's syndrome: the expression of certain cascade and regulatory proteins in labial salivary glands - observational study

Marta Legatowicz-Koprowska et al. Reumatologia. 2020.

Abstract

Introduction: The complement cascade and regulatory proteins are involved in the pathogenesis of the Sjögren's syndrome and other autoimmune diseases. The complement activation via the alternative pathway was recognized as a major pathogenic mechanism in autoimmune conditions. The aim of this study was to assess expression of complement cascade components and regulatory proteins in minor salivary glands in patients with primary Sjögren's syndrome (pSS).

Materials and methods: The expression of C1q and C5b-9 - membrane attack complex and regulatory proteins such as: membrane cofactor protein (MCP), decay-accelerating factor (DAF) and protectin were examined using immunochemistry method in specimens from biopsy of minor salivary glands in pSS patients. The biopsy material was obtained from 20 pSS patients, 5 patients with non-specific sialadenitis and from 5 patients with suspicion of dryness syndrome without sialadenitis confirmation.

Results: None of the examined samples showed the expression of C1q or the effector C5b-9. Membrane cofactor protein expression was lower in pSS group than in both non-specific sialadenitis and noninflamed salivary glands. The inflammatory cells in pSS samples partially expressed MCP. There were differences in the sites and intensity of membrane protectin expression exclusively on the luminal surfaces in pSS; on the luminal and, partially, antiluminal surface in non-specific inflammation, and on the entire cell surface in unaffected salivary glands. There were no DAF expression in salivary gland tissue in biopsy specimens in all studied subjects.

Conclusions: The study demonstrated the absence of complement-cascade proteins (C1q, MAC) in the salivary glands of pSS patients, which may indicated a lack of local complement activation via the classical pathway and the observed gland tissue damage being due to a mechanism other than MAC-induced cytolysis. The differences in the expression of complement regulatory proteins between pSS, non-specific sialadenitis, and normal salivary glands may indicate that alternative functions of these regulatory proteins may be of greater significance in pSS. Low MCP expression in pSS in comparison with non-specific sialadenitis and normal salivary glands, may suggest altered modulation of cell-mediated immunity in pSS. The differences in the location and intensity of protectin (CD59) expression indicates a possibility of reducing the proinflammatory effect of protectin in pSS.

Keywords: complement system proteins; membrane cofactor protein CD46; primary Sjogren’s syndrome; protectin CD59.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
The three main activation pathways of complement: the classical, mannose-binding lectin, and alternative pathways (according to Bora NS [10] – modified). The proteins under examinations in red borders.
Fig. 2
Fig. 2
IHC staining for CD46 (A–C). pSS – intensive reaction of lymphocytes – arrows (A), non-specific sialadenitis: markedly positive (+++) reactions on the surface of ductal epithelium (B), normal salivary glands: homogeneously positive reaction (+++) with anti-MCP on nearly all acinar cell membranes (C). IHC staining for CD59 (D–F). pSS – CD59 homogeneously pronounced positive expression only on luminal surface of acinar and ductal cells (D), non-specific sialadenitis: luminal-surface reactions (+)/(++), with positive (+)/(++) reactions observed on the entire surface of acinar cells (E), normal salivary glands: predominantly highly positive reactions on the entire surfaces of acinar and ductal epithelial cells (F). All pictures magnification × 200.

Similar articles

Cited by

References

    1. Shiboski CH, Shiboski SC, Seror R, et al. Criteria 2016 ACR-EULAR Classification Criteria for primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017;69:35–45. doi: 10.1002/art.39859. - DOI - PMC - PubMed
    1. Carubbi F, Alunno A, Cipriani P, et al. A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome. Lupus. 2015;24:315–320. doi: 10.1177/0961203314554251. - DOI - PubMed
    1. Ramos-Casals M, Brito-Zerón P, Yagüe J, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren’s syndrome. Rheumatology (Oxford) 2005;44:89–94. doi: 10.1093/rheumatology/keh407. - DOI - PubMed
    1. Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjögren’s syndrome, the old and the new. Best Pract Res Clin Rheum. 2012;26:105–117. doi: 10.1016/j.berh.2012.01.012. - DOI - PubMed
    1. Nair JJ, Singh TP. Sjogren syndrome: Review of the aetiology, pathophysiology & potential therapeutic interventions. J Clin Exp Dent. 2017;9:e584–e589. - PMC - PubMed